Calcineurin A-α but not A-β is required for normal kidney development and function

American Journal of Pathology

Volumn 165, Issue 5, 2004, Pages 1755-1765

  Gooch, Jennifer L ^a,b   Toro, Juan J ^a,b   Guler, Rebecca L ^a,b   Barnes, Jeffrey L ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CALCINEURIN A ALPHA; CALCINEURIN A BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; GLOMERULUS; KIDNEY DEVELOPMENT; KIDNEY FUNCTION; MOUSE; NEPHRON; NONHUMAN; PHENOTYPE; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

EID: 7244250009     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63430-X     Document Type: Article

References (35)

1. Rusnak F, Mertz P: Calcineurin: form and function. Physiol Rev 2000 80:1433-1521
2. Suzuki E, Nishimatsu H, Satonaka H, Walsh K, Goto A, Omata M, Fujita T, Nagai R, Hirata Y: Angiotensin II induces myocyte enhancer factor 2- and calcineurin/nuclear factor of activated T cell-dependent transcriptional activation in vascular myocytes. Circ Res 2002, 90:1004-1011
3. Mural A, Pellieux C, Brunner H-R, Pedrazzini T: Calcineurin blockade prevents cardiac mitogen-activated protein kinase activation and hypertrophy in renovascular hypertension. J Biol Chem 2000, 275:40867-40873
4. Lea J, Kin S, Roberts B, Shuler M, Marrero M, Tumlin J: Angiotensin II stimulates calcineurin activity in proximal tubule epithelia through AT-1 receptor-mediated tyrosine phosphorylation of the PLC-γ1 isoform. J Am Soc Nephrol 2002, 13:1750-1756
5. Gooch JL, Tang Y, Ricono JM, Abboud HE: Insulin-like growth factor-1 induces renal cell hypertrophy via a calcineurin-dependent mechanism. J Biol Chem 2001, 276:42492-42500
6. Musaro A, McCullagh KJ, Naya FJ, Olsen EN, Rosenthal N: IGF-1 induces skeletal myocyte hypertrophy in association with GATA-2 and NF-ATc1. Nature 1999, 400:581-585
7. Pons S, Torres-Aleman I: Insulin-like growth factor-I stimulates dephosphorylation of IkB through the serine phosphatase calcineurin (protein phosphatase 2B). J Biol Chem 2000, 275:38620-38625
8. 2+- dependent calcineurin signalling pathway. Nature 1999, 400:576-580
9. Gooch JL, Gorin Y, Zhang BX, Abboud HE: Involvement of calcineurin in TGFβ-mediated regulation of extracellular matrix accumulation. J Biol Chem 2004, 279:15561-15570
10. 231. Mol Pharmacol 1999, 55:632-641
11. Mandelkow E-M, Bjiernat J, Drewes G, Gustke N, Trinczek B, Mandelkow E: Tau domains, phosphorylation, and interactions with microtubules. Neurobiol Aging 1995, 16:355-363
12. Ladner C, Czech J, Maurice J, Lorens S, Lee J: Reduction of calcineurin anzymatic activity in Alzheimer's disease: correlation with neuropathologic changes. J Neuropathol Exp Neurol 1996, 55:924-931
13. Molkentin J, Lu J, Antos C, Markham B, Richardson J, Robbins J, Grant S, Olsen E: A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998, 93:215-228
14. DeWindt J, Lim H, Taigen T, Wencker D, Condorelli G, Dorn Gn, Kitsis R, Molkentin J: Calcineruin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: an apoptosis-independent model of dilated heart failure. Circ Res 2000, 86:255-263
15. Taigen T, De Windt LJ, Lim HW, Molkenten JD: Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy. Proc Natl Acad Sci USA 2000, 97:1196-1201
16. Johnson DW, Saunders HJ, Johnson FJ, Huq SO, Field MJ, Pollock CA: Cyclosporin exerts a direct fibrogenic effect on human tubuloin-terstitial cells: roles of insulin-like growth factor I, transforming growth factor β1, and platelet-derived growth factor. J Pharmacol Exp Ther 1999, 289:535-542
17. Wolf G, Killen PD, Neilson EG: Cyclosporin A stimulates transcription and procollagen secretion in tubulointersititial fibroblasts and proximal tubule cells. J Am Soc Nephol 1990, 6:918-922
18. Gooch JL, Pergola PE, Guler RL, Abboud HE, Barnes JL: Differential expression of calcineurin A isoforms in the diabetic kidney. J Am Soc Nephol 2004, 15:1421-1429
19. Kayyali U, Zhang W, Yee A, Seidman J, Potter H: Cytoskeletal changes in the brains of mice lacking calcineurin A α. J Neurochem 1997, 68:1668-1678
20. Zhuo M, Zhang W, Son H, Mansuy I, Sobel R, Seidman J, Kandel E: A selective role of calcineurin A áin synaptic depotentiation in hippocampus. Proc Natl Acad Sci USA 1999, 96:4650-4655
21. Zhang B, Zimmer G, Chen J, Ladd D, Li E, Alt F, Wiederrecht G, Cryan J, O'Neill E, Seidman C, Abbas A, Seidman J: T cell responses in calcineurin A α-deficient mice. J Exp Med.1996, 183:413-420
22. Chan VS, Wong C, Ohashi PS: Calcineurin Aα plays an exclusive role in TCR signaling in mature but not immature T cells. Eur J Immunol 2002, 32:1223-1229
23. Bueno OF, Brandt EB, Rothenberg ME, Molkentin JD: Defective T cell development and function in calcineurin A β-deficient mice. Proc Natl Acad Sci USA 2002, 99:9398-9403
24. Bueno OF, Wilkins BJ, Tymitz KM, Glascock BJ, Kimball TF, Lorenz JN, Molkentin JD: Impaired cardiac hypertrophic response in calcineurin A β-deficient mice. Proc Natl Acad Sci USA2002, 99:4586-4591
25. Parsons SA, Wilkins BJ, Bueno OF, Molkentin JD: Altered skeletal muscle phenotypes in calcineurin Aα and Aβ gene-targeted mice. Mol Cell Biol 2003, 23:4331-4343
26. Graef I, Chen F, Chen L, Kuo A, Crabtree G: Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature. Cell 2001, 105:863-875
27. Fruman DA, Pai S-Y, Klee CN, Burakoff SJ, Bierer BE: Measurement of calcineurin phosphatase activity in cell extracts. Methods Enzymol 1996, 9:146-154
28. Combs HL, Shankland SJ, Setzer SV, Hudkins KL, Alpers CE: Expression of the cyclin kinase inhibitor, p27kip1, in developing and mature human kidney. Kidney Int 1998, 53:892-896
29. Ledford AW, Brantley JG, Kemeny G, Foreman TL, Quaggin SE, Igarashi P, Oberhaus SM, Rodova M, Calvet JP, Vanden Heuvel GB: Deregulated expression of the homeobox gene Cux-1 in transgenic mice results in downregulation of p27(kip1) expression during nephrogenesis, glomerular abnormalities, and multiorgan hyperplasia. Dev Biol 2002, 245:157-171
30. Brantley JG, Sharma M, Alcalay NI, Heuvel GB: Cux-1 transgenic mice develop glomerulosclerosis and interstitial fibrosis. Kidney Int 2003, 63:1240-1248
31. Tumlin JA, Someren JT, Swanson CE, Lea JP: Expression of calcineurin activity and α-subunit isoforms in specific segments of the rat nephron. Am J Physiol 1995, 269:F558-F563
32. Tendron A, Decramer S, Justrabo E, Gouyon JB, Semama DS, Gilbert T: Cyclosporin A administration during pregnancy induces a permanent nephron deficit in young rabbits. J Am Soc Nephrol 2003, 14:3188-3196
33. Chang CP, McDill BW, Neilson JR, Joist HE, Epstein JA, Crabtree GR, Chen F: Calcineurin is required in urinary tract mesenchyme for the development of the pyeloureteral peristaltic machinery. J Clin Invest 2004. 113:1051-1058
34. Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, Horii I, Loh DY: Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 1996, 85:707-720
35. Gooch JL, Barnes JL, Garcia S, Abboud HE: Calcineurin is activated in diabetes and is required for glomerular hypertrophy and ECM accumulation. Am J Physiol Renal Physiol 2003, 284:F144-F154